Related Experiment Videos
Low-dose intravenous immunoglobulin therapy for intractable dermatomyositis skin lesions
T Sadayama1, S Miyagawa, T Shirai
1Department of Dermatology, Nara Medical University, Japan.
The Journal of Dermatology
|August 24, 1999
Abstract:
We report a 45-year-old female patient with dermatomyositis whose corticosteroid-resistant cutaneous manifestations improved with low-dose (0.1 g/kg body weight/day for 5 days weekly for 2 weeks) intravenous immunoglobulin (IVIG) therapy.